Data / Form D filings / LUMICELL, INC.
LUMICELL, INC.: Form D filings
LUMICELL, INC., a biotechnology company in Newton, MA, filed 10 Form D notices with the SEC between 2011 and 2025. The latest, on May 6, 2025, reports $198.1 million sold of an offering with no set size to 64 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 275 WASHINGTON STREET, STE. 200, Newton, MA, 02458
- Phone
- (617) 404-1001
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1521898
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 6, 2025 | New notice | Indefinite | $198,128,718 | 64 | Apr 22, 2025 | sec.gov | |
| Jul 25, 2024 | New notice | $12,000,000 | $2,730,612 | $9,269,388 | 11 | Jul 11, 2024 | sec.gov |
| Mar 8, 2024 | New notice | Indefinite | $2,275,000 | 6 | Feb 22, 2024 | sec.gov | |
| Jul 26, 2023 | New notice | $110,204,111 | $75,843,150 | $34,360,961 | 47 | Jul 14, 2023 | sec.gov |
| Dec 20, 2018 | New notice | $35,000,004 | $20,365,906 | $14,634,098 | 25 | Dec 7, 2018 | sec.gov |
| Oct 18, 2017 | New notice | $26,505,014 | $20,705,024 | $5,799,990 | 24 | Jun 28, 2017 | sec.gov |
| May 4, 2016 | New notice | $10,000,000 | $6,769,997 | $3,230,003 | 10 | Apr 20, 2016 | sec.gov |
| Feb 25, 2014 | Amendment | $1,563,572 | $1,563,572 | 7 | Dec 19, 2013 | sec.gov | |
| Jan 3, 2014 | New notice | $1,013,582 | $1,013,582 | 5 | Dec 19, 2013 | sec.gov | |
| Jun 1, 2011 | New notice | $3,908,237 | $2,708,236 | $1,200,001 | 4 | May 18, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrey J. Zarur | Director | |
| Elon J. Boms | Director | |
| Jorge Ferrer | Executive Officer | |
| David J. Furneaux | Director | |
| Kevin J. Krenitsky | Director | |
| James J. Alecxih | Director | |
| Carlos J. Gonzalez | Director | |
| Howard Hechler | Executive Officer, Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of May 5, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what LUMICELL, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.